Karel Kostev to Treatment Outcome
This is a "connection" page, showing publications Karel Kostev has written about Treatment Outcome.
Connection Strength
0.160
-
Differences in baseline characteristics between type 2 diabetes mellitus patients treated with dipeptidyl peptidase-4 inhibitors in randomized controlled trials and those receiving the same treatment in real-world settings?. Int J Clin Pharmacol Ther. 2018 Sep; 56(9):411-416.
Score: 0.028
-
Prevalence and treatment of sexually transmitted diseases in gynecological practices in Germany: A retrospective study with more than 1,000,000 patients?. Int J Clin Pharmacol Ther. 2018 May; 56(5):212-216.
Score: 0.027
-
The Influence of Polypharmacy on the Initiation of Anti-Dementia Therapy in Germany. J Alzheimers Dis. 2018; 64(3):827-833.
Score: 0.027
-
Regional differences in insulin therapy regimens in five European countries?. Int J Clin Pharmacol Ther. 2017 May; 55(5):403-408.
Score: 0.026
-
Association between Anti-Dementia Treatment Persistence and Daily Dosage of the First Prescription: A Retrospective Analysis in Neuropsychiatric Practices in Germany. J Alzheimers Dis. 2017; 58(1):37-44.
Score: 0.025
-
Current healthcare pathways in the treatment of rhinosinusitis in Germany. Acta Otolaryngol. 2018 Dec; 138(12):1086-1091.
Score: 0.007
-
Diagnosing and treating dementia in German primary and specialized care between 2011 and 2015?. Int J Clin Pharmacol Ther. 2018 Jul; 56(7):301-309.
Score: 0.007
-
Treatment patterns and low-density lipoprotein cholesterol (LDL-C) goal attainment among patients receiving high- or moderate-intensity statins. Clin Res Cardiol. 2018 May; 107(5):380-388.
Score: 0.007
-
Prevalence of bisphosphonate therapy in women with breast cancer treated with aromatase inhibitors in Germany?. Int J Clin Pharmacol Ther. 2017 May; 55(5):394-396.
Score: 0.006